Td Asset Management Inc Cytokinetics Inc Transaction History

Td Asset Management Inc

$108 Billion
Q2 2025

A detailed history of Td Asset Management Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Td Asset Management Inc holds 544,292 shares of CYTK stock, worth $32.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

544,292

Previous 446,828 21.81%

Holding current value

$32.3 Million

Previous $18 Million 0.14%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	BUY	$29.84 - $42.92 $2.91 Million - $4.18 Million	97,464 Added 21.81%	544,292 $18 Million
Q1 2025 May 07, 2025	SELL	$40.19 - $51.12 $3.13 Million - $3.98 Million	-77,806 Reduced 14.83%	446,828 $18 Million
Q4 2024 Feb 11, 2025	SELL	$46.36 - $58.62 $1.69 Million - $2.13 Million	-36,384 Reduced 6.49%	524,634 $24.7 Million
Q3 2024 Nov 01, 2024	BUY	$51.22 - $60.16 $10.3 Million - $12.1 Million	200,420 Added 55.58%	561,018 $29.6 Million
Q2 2024 Aug 02, 2024	BUY	$47.86 - $75.05 $3.64 Million - $5.71 Million	76,078 Added 26.74%	360,598 $19.5 Million
Q1 2024 May 08, 2024	BUY	$63.75 - $108.06 $6.53 Million - $11.1 Million	102,480 Added 56.3%	284,520 $19.9 Million
Q4 2023 Feb 12, 2024	BUY	$26.88 - $83.49 $2.21 Million - $6.88 Million	82,400 Added 82.7%	182,040 $15.2 Million
Q3 2023 Oct 27, 2023	BUY	$29.46 - $36.61 $774,709 - $962,733	26,297 Added 35.85%	99,640 $2.94 Million
Q2 2023 Aug 09, 2023	SELL	$32.62 - $40.75 $19,572 - $24,450	-600 Reduced 0.81%	73,343 $2.39 Million
Q1 2023 May 10, 2023	BUY	$33.36 - $45.71 $760,608 - $1.04 Million	22,800 Added 44.58%	73,943 $2.6 Million
Q4 2022 Feb 06, 2023	BUY	$35.77 - $51.11 $450,702 - $643,986	12,600 Added 32.69%	51,143 $2.34 Million
Q3 2022 Nov 07, 2022	BUY	$38.54 - $54.52 $331,444 - $468,872	8,600 Added 28.72%	38,543 $1.89 Million
Q2 2022 Aug 04, 2022	SELL	$33.93 - $48.92 $18,899 - $27,248	-557 Reduced 1.83%	29,943 $1.18 Million
Q1 2022 May 10, 2022	BUY	$29.74 - $46.0 $657,254 - $1.02 Million	22,100 Added 263.1%	30,500 $1.12 Million
Q4 2021 Feb 10, 2022	BUY	$34.35 - $46.38 $288,540 - $389,592	8,400 New	8,400 $383,000
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $544,782 - $1.02 Million	-35,700 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$20.58 - $28.96 $734,705 - $1.03 Million	35,700 New	35,700 $773,000
Q1 2018 May 11, 2018	SELL	$7.2 - $10.05 $131,760 - $183,915	-18,300 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$12.0 - $15.0 $219,600 - $274,500	18,300	18,300 $265,000

Others Institutions Holding CYTK

# of Institutions

380

Shares Held

129M

Call Options Held

3.62M

Put Options Held

1.14M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.59B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Cytokinetics Inc Transaction History